Correlation between clonotypic T-cell receptor beta chain variable region (TCR-V(β)) gene expression and aberrant T-cell antigen expression in cutaneous T-cell lymphoma

Journal of Cutaneous Pathology

Volumn 23, Issue 4, 1996, Pages 306-311

  Finn, Daniel T ^a   Jaworsky, Christine ^b   Chooback, Lilian ^c,d   Jensen, Pamela J ^c,d   Lessin, Stuart R ^c,d,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH TEXAS   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; EPIDERMIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PARAPSORIASIS; SKIN BIOPSY; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0029761954     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb01302.x     Document Type: Article

References (25)

1. Greer J, Salhany K, King L. Cutaneous T-cell lymphoma: mycosis fungoides and Sezary syndrome. In: Lee G et al, ed: Clinical Hematology (9th edn.). Philadelphia: Lea & Febfiger, 1993: 2143.
2. Shapiro P, Pinto F. The histologic spectrum of mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma). Am J Surg Pathol 1994: 18: 645.
3. Olerud J, Kulin P, Chew D, et al. Cutaneous T-cell lymphoma: evaluation of pretreatment skin biopsy specimens by a panel of pathologists. Arch Dermatol 1992: 128: 501.
4. van der Putte SCJ, ToonstraJ, van Wichen DF, van Unnik JAM, van Vloten WA. Aberrant immunophenotypes in mycosis fungoides. Arch Dermatol 1988: 124: 373.
5. Kung E, Meissner K, Loning T. Cutaneous T cell lymphoma: immunocytochemical study on activation/proliferation and differentiation associated antigens in lymph nodes, skin, and peripheral blood. Virchows Arch A Pathol Anat 1988: 413: 539.
6. Wood GS, Hong SR, Sasaki DT, et al. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values. J Am Acad Dermatol 1990:22:602.
7. Charley M, McCoy JP, Deng J-S, Jegasothy B. Anti-V region antibodies as "almost clonotypic" reagents for the study of cutaneous T cell lymphomas and leukemias. J Invest Dermatol 1990:95:614.
8. Hunt SJ, Charley MR, Jegasothy BV. Cutaneous T-cell lymphoma: utility of antibodies to the variable regions of the human T-cell antigen receptor. J Am Acad Dermatol 1992: 26: 552.
9. Bagot M, Wechsler J, Lescs M-C, Revuz J, Farcet J-P. Intraepidermal localization of the clone in cutaneous T-cell lymphoma. J Am Acad Dermatol 1992: 27: 589.
10. Fivenson D, Nickoloff B. Immunodiagnosis in cutaneous T cell lymphoma: how does gene expression of the variable region of the T cell receptor fit into the diagnostic and pathophysiological picture of T cell neoplasia. J Cutan Pathol 1992: 19: 1.
11. β gene segments by Sezary cells. J Invest Dermatol 1995: 105: 56.
12. Jensen P, Wu Q, Janowitz P, Ando Y, Schecter N. Plasminogen activator inhibitor type 2: an intracellular keratinocyte differentiation product that is incorporated into the cornified envelope. Exp Cell Res 1995: 217: 65.
13. Burg G. Small plaque (digitate) parapsoriasis is an "abortive cutaneous T-cell lymphoma" and is not mycosis fungoides. Arch Dermatol 1995: 131: 336.
14. β T-cell receptor gene locus: direct primer-walking using cosmid template DNAs. Genomics 1994: 20: 149.
15. Wei S, Charmley P, Robinson M, Concannon P. The extent of the human germline T-cell receptor V beta segment repertoire. Immunogenetics 1994: 40: 27.
16. Bahler D, Berry G, Warnke R, Lew R. Diversity of T-cell antigen receptor variable genes used by mycosis fungoides cells. Am J Pathol 1992: 140: 1.
17. β gene diversity in Sezary syndrome. Am J Pathol 1992: 140: 823.
18. β gene products: rapid demonstration of clonality in cutaneous T cell lymphoma? J Cutan Pathol 1993: 20: 540.
19. Vowels BR, Lessin SR, Cassin M, et al. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 1994: 103: 669.
20. Wood G, Edinger A, Hoppe R, Warnke R. Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype. J Cutan Pathol 1994: 21: 151.
21. Weiss LM, Wood GS, Ellisen LW, Reynolds TC, Sklar J. Clonal T cell populations in pityriasis lichenoides et variolaformis acuta (Mucha-Habermann disease). Am J Pathol 1987: 126: 417.
22. β13.1 genes. Proc Natl Acad Sci USA 1994: 91: 9282.
23. Michie SA, Abel EA, Hoppe RT, Warnke RA, Wood GS. Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides. Am J Pathol 1991: 137: 1447.
24. Gilks C, Ho V, Gascoyne R, Ellison D. T-cell receptor variable region gene expression in cutaneous T-cell lymphomas. J Cutan Pathol 1992: 19: 21.
25. Davis M, Bjorkman P. T-cell antigen receptor genes and T-cell recognition. Nature 1988: 334: 395.